# A Pharmacokinetic Study of Oral Cyclophosphamide and Topotecan in Children With Recurrent Solid Tumors

> **NCT00628732** · PHASE2 · COMPLETED · sponsor: **Children's Medical Center Dallas** · enrollment: 36 (estimated)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** Cyclophosphamide and Topotecan

## Key facts

- **NCT ID:** NCT00628732
- **Lead sponsor:** Children's Medical Center Dallas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2009-01-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00628732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00628732, "A Pharmacokinetic Study of Oral Cyclophosphamide and Topotecan in Children With Recurrent Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00628732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*